Peptide therapy on TikTok: separating hype from human data

What's this video probably claiming?

Based on the category tag and the @cranelabs account context, this video almost certainly touches on one or more of the peptides currently dominating the biohacker conversation: BPC-157, TB-500, CJC-1295 with or without ipamorelin, GHK-Cu, or MK-677. The typical content formula here is a listicle-style breakdown, something like "the peptides I'm actually using and why," or a comparison between stacks for recovery versus body composition. Creators in this space tend to present these compounds as personalized optimization tools backed by research, often citing rat studies as if they translate cleanly to human physiology. The framing is usually part personal testimony, part pseudo-clinical explainer. The implicit message is almost always that these peptides are underused, suppressed by mainstream medicine, and accessible to anyone willing to do their homework. That framing deserves scrutiny before any viewer takes it as guidance.

What does the science actually show?

The honest answer is: a lot of promising preclinical data, very little rigorous human data. BPC-157 has generated genuine interest since Sikiric et al. published extensively on its gastroprotective and tendon-healing effects in rodents through the 1990s and 2000s, but as of 2024 there are no completed Phase 2 or Phase 3 human trials. TB-500 (thymosin beta-4) has shown angiogenic and anti-inflammatory activity in animal models; a 2010 study by Philp et al. in Annals of the New York Academy of Sciences outlined mechanisms, but human wound-healing trials have been small and underpowered. CJC-1295 with ipamorelin does produce measurable increases in growth hormone pulse amplitude in humans, documented by Teichman et al. in the Journal of Clinical Endocrinology and Metabolism (2006), but whether that translates to meaningful fat loss or muscle gain in healthy adults at real-world doses is a different question. MK-677 is not a peptide but a ghrelin mimetic; the Nass et al. trial in NEJM (2008) showed IGF-1 increases in older adults alongside significant water retention and insulin resistance signals. GHK-Cu copper peptide skin data is largely in vitro.

Where does the social media noise diverge from clinical reality?

The biggest divergence is in how creators handle the rat-to-human translation problem. A rodent study showing 80% tendon strength recovery after BPC-157 injection is interesting. It is not evidence that injecting yourself subcutaneously will fix your shoulder. Rat pharmacokinetics, dosing ratios scaled by body weight, and injury models in controlled settings share almost nothing with a person self-injecting a gray-market compound of unknown purity. The second major distortion is around safety. Peptides are often framed as "side-effect free" compared to steroids or pharmaceuticals. That comparison is unfair and potentially dangerous. MK-677 has documented effects on fasting glucose and insulin sensitivity. Semax and selank have almost no long-term human safety data at all. Third, creators rarely mention that most peptides available online are research chemicals with no manufacturing quality controls, no batch testing for endotoxins, and no regulatory oversight. The FDA issued warnings specifically about BPC-157 in 2022 as part of its broader crackdown on compounded peptides, citing insufficient clinical evidence for safety and effectiveness.

What should you actually know?

Some of these compounds may eventually prove clinically useful. The peptide category is not pseudoscience in the way homeopathy is. The mechanisms are real, the preclinical literature is substantive, and legitimate research is ongoing. But "plausible mechanism" is not the same as "proven benefit," and that gap is where TikTok content lives. If you are considering any peptide therapy, the questions that actually matter are: Is it prescribed by a licensed provider who reviewed your labs? Is it compounded by a 503B-licensed pharmacy with CoA documentation? Is your provider tracking outcomes and adjusting accordingly? Self-injection of gray-market peptides based on a 60-second video is not optimization. It is an uncontrolled experiment on yourself with no safety net. The compounds that have the most online enthusiasm, BPC-157, TB-500, semax, selank, are precisely the ones with the least human safety data. That is worth sitting with before you order anything.